To systematically review the ultrasonographic criteria proposed for the diagnosis of chronic cerebrospinal venous insufficiency (CCSVI). The authors analyzed the five ultrasonographic criteria, four extracranial and one intracranial, suggested for the diagnosis of CCSVI in multiple sclerosis (MS), together with the references from which these criteria were derived and the main studies that explored the physiology of cerebrospinal drainage. The proposed CCSVI criteria are questionable due to both methodological and technical errors: criteria 1 and 3 are based on a scientifically incorrect application of data obtained in a different setting; criteria 2 and 4 have never been validated before; criterion 2 is technically incorrect; criteria 3 and 5 are susceptible to so many external factors that it is difficult to state whether the data collected are pathological or a variation from the normal. It is also unclear how it was decided that two or more of these five ultrasound criteria may be used to diagnose CCSVI, since no validation of these criteria was performed by different and independent observers nor were they blindly compared with a validated gold-standard investigation. The European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) has considerable concerns regarding the accuracy of the proposed criteria for CCSVI in MS. Therefore, any potentially harmful interventional treatment such as transluminal angioplasty and/or stenting should be strongly discouraged.
Background
It is widely accepted that patients with rheumatoid arthritis (RA) have increased mortality and morbidity from premature cardiovascular disease. Up to 50% of this mortality excess is secondary to ischemic heart disease closely followed by cerebrovascular disease [1].
Objectives
To investigate intima-media thickness (IMT) and plaque formation with relation to age, disease duration and disease severity, myocardial infarction (MI) and stroke in patients with RA in order to detect and estimate cardio and cerebrovascular risk factors and events.
Methods
Forty five patients (female 91.1%) with confirmed RA (aged 20-82) were selected. Carotid artery hemodynamic parameters, IMT and plaques were measured by using high resolution B-mode and Doppler–mode ultrasound to detect blood flow velocities, maximal IMT, size of atherosclerotic plaques. Rheumatoid arthritis severity was measured by DAS28, SDAI, CDAI scores and HAQ questionnaires. For cardiovascular risk detection Framingham risk score and AIP (Atherogenic Index of Plasma (log10 TG/HDLC)) were used. Data analysis was performed using IBM SPSS 21.0.
Results
Patients with previous MI were statistically significant older than patients without MI (69.0±10.6 and 52.7±15.7 years, respectively). Previous MI had 13.33% of patients, and previous stroke 4.44% of patients. There were no statistically significant correlations between atherosclerotic plaques on the right and left side of brachiocephalic vessels, IMT dx and sin, and the duration of RA and the age when diagnosis was confirmed (p>0.05). Statistically significant correlation between IMT sin and age of patients was found (r=0.63; p<0.001); IMT dx and age of patient (r=0.62; p<0.001). No statistically significant correlations between IMT dx and sin, atherosclerotic plaques dx and sin and activity markers of RA (p>0.05) were found. The duration of disease was not statistically longer for patient with MI than for patients without MI (p=0.34). Atherosclerotic lesions were not more pronounced to patients with MI than without (p=0.80). Anti CCP levels did not differ between patients with and without MI (p=0.900).
Conclusions
Previous MI did not show significant association with BMI, smoking habits, atherosclerotic lesions of vessels (atherosclerotic plaques), disease severity, activity markers and AIP. This preliminary observation indicates the changes of immune system long before appearance of RA, triggering severe cardiovascular events without traditional cardiovascular risk factors.
References
Wallberg-Jonsson S, Ohman ML, Dahlqvist SR:Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J. Rheumatol 1997;24:445–51.
Disclosure of Interest
None declared
DOI
10.1136/annrheumdis-2014-eular.5841
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.